Dr Ariane Lewis discusses how we can navigate uncertainty and ambiguity about brain death by understanding clinical criteria for brain death determination and how our approaches to death are culturally and socially situated.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
In the 1910s, the American Medical Association fought quackery promoted in pamphlets for drugs and treatments for everything from teething to epilepsy.
AMA J Ethics. 2018;20(11):E1082-1093. doi:
10.1001/amajethics.2018.1082.
Dr Jeff Sebo joins Ethics Talk to discuss his article, coauthored with Zoe Griffiths: "How Should We Improve How Medical and Veterinary Students Learn About Human and Nonhuman Animals?"
Watie White joins Ethics Talk to discuss his article, coauthored with Dr Regina Idoate, Aislinn C. Rookwood, Sophia A. Quintero, Shelby Larson, Dr Arturo Aceves, and Dr Keyonna M. King: “Lead Toxicity and Environmental Health Justice Stories in Black and White Woodcut Portraits.”
Regina Idoate, PhD, Aislinn C. Rookwood, MPH, Sophia A. Quintero, MPH, Watie White, MFA, Shelby Larson, MPH, Arturo Aceves, MD, and Keyonna M. King, DrPH, MA
Healthy Housing Omaha, an environmental health nonprofit, partnered with an artist and a newspaper to raise awareness of lead poisoning.
AMA J Ethics. 2022;24(7):E599-610. doi:
10.1001/amajethics.2022.599.